Thomas Alva Edison April 5 New York City
The awards were judged by a group of marketing professionals and academics in a comprehensive peer-review process that focused on Societal Impact, Marketplace Innovation and Success, Technological Innovation and Market Structure Innovation.
MedApps®, one of three remaining finalists in its category, provides an innovative wireless technology platform featuring products and services for the remote monitoring of patients with chronic conditions including diabetes, hypertension and congestive heart failure. The FDA-cleared MedApps System automatically collects health readings from popular retail medical monitors and forwards the data to the patient’s electronic health record. MedApps has demonstrated that its remote monitoring solutions—which it describes as simple, flexible and mobile—can help drive down healthcare costs and stabilize or improve patient health through proactive healthcare delivery, resulting in increased communication and compliance.
The Edison Awards recognizes MedApps’ wide-range vision and product roadmap that includes HealthPAL®, HealthHUB™, HealthAIR™, HealthCOM®, the upcoming HealthREADER™ & SmartCard, and MedApps Kiosk System – all of which are brought together by the MedApps CloudCare™ platform.
"We’ve already achieved a great deal of success with HealthPAL and our HealthCOM System," continues Dicks. "We realized early on that the solutions that would work best had to focus on the patients and care providers needs, while making the technology function discretely in the background – and to accomplish this, one solution simply will not fit all."
MedApps’ products and services can integrate with wired or wireless monitors from a number of trusted manufacturers, as well as enterprise EHRs and consumer PHRs. As MedApps adds more driver-model based products to its cloud-based infrastructure, the System will allow patients and providers to engage in a healthcare delivery model that best suits their needs – offering a wide range of price points and features.
The CloudCare platform allows for automated, remote installation and updating of firmware in the field, which essentially allows MedApps’ devices to self-configure with patient monitors with little or no user interaction. This ideal of simple, seamless and "invisible" connectivity has been recognized in previous Edison Award winners such as Kindle™, OnStar® and Apple® iPhone™.
Beyond its technological innovation, the MedApps System has demonstrated unique "societal impact", at a number of cutting-edge healthcare facilities across the country, through its ability to empower patients to self-manage their chronic conditions and improve their compliance. In particular, a very successful pilot, whose focus was to reduce incidents of re-hospitalization for CHF (congestive heart failure) patients released from acute care, achieved a 100% success rate with no re-admissions within 30 days.
This program and others has shown that remote monitoring can deliver a significant return on investment, effectively addressing the needs of payers and providers who are fiscally responsible for large populations. And as the chronic disease epidemic escalates, it is imperative that these companies drive down the costs associated with care. Furthermore mHealth’s ability to maximize resources while reducing costs will play a key role in enabling our country’s initiatives for healthcare reform.
Sarah Miller Caldicott Thomas Edison Thomas Edison
New Jersey http://www.medapps.com
SOURCE MedApps, Inc.